OTCMKTS:OPHLF Ono Pharmaceutical (OPHLF) Stock Price, News & Analysis $14.95 0.00 (0.00%) As of 10/2/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsNews and TrendsShort Interest About Ono Pharmaceutical Stock (OTCMKTS:OPHLF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Ono Pharmaceutical alerts:Sign Up Key Stats Today's Range$14.95▼$14.9550-Day Range$13.67▼$16.5052-Week Range$11.08▼$18.67VolumeN/AAverage Volume3,140 shsMarket Capitalization$7.03 billionP/E Ratio14.24Dividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Ono Pharmaceutical Co., Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and commercialization of prescription medicines. The company focuses primarily on oncology, immunology, neurology and other specialty therapeutic areas, with an emphasis on discovering treatments for diseases with significant unmet medical needs. Ono’s best-known product is Opdivo (nivolumab), an immuno-oncology medicine developed in collaboration with Bristol Myers Squibb and approved for multiple cancer indications in various markets. The company also markets and develops additional medicines through its own research programs and collaborations with global pharmaceutical and biotechnology companies. Founded in Osaka in 1717 as a pharmaceutical wholesaler, Ono has evolved into a research-based drug manufacturer with operations and commercial activities in Japan and international markets. Its products are distributed globally through subsidiaries and strategic partnerships. The company is headquartered in Osaka, Japan, and is led by President and Chief Executive Officer Gyo Sagara.AI Generated. May Contain Errors. Read More Receive OPHLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ono Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OPHLF Stock News HeadlinesOno Pharmaceutical Co. (OPHLF) Soars 13.9%: Is Further Upside Left in the Stock?September 24, 2026 | finance.yahoo.comOno Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological DiseasesSeptember 1, 2026 | businesswire.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.October 4 at 1:00 AM | Altimetry (Ad)Ono Pharma’s New Cancer Trial Adds Early-Stage Upside—and Risk—for OPHLF InvestorsAugust 26, 2026 | tipranks.comOno Pharma Halts Early Lymphoma Trial, Raising Fresh Questions for InvestorsJuly 29, 2026 | tipranks.comOno’s New GIST Study Puts Early‑Stage Oncology Back in Focus for OPHLF InvestorsJuly 20, 2026 | tipranks.comOno Pharmaceutical Co. (OPHLF) moves 10.4% higher: Will this strength last?July 7, 2026 | msn.comOno Pharma Announces Oral Presentation of New Data from the Phase 2 Clinical Study of ONO-4578 (EP4 antagonist) in Certain Gastric Cancers at the ASCO 2026 Annual MeetingJune 1, 2026 | businesswire.comSee More Headlines OPHLF Stock Analysis - Frequently Asked Questions How have OPHLF shares performed this year? Ono Pharmaceutical's stock was trading at $12.8696 at the start of the year. Since then, OPHLF stock has increased by 16.2% and is now trading at $14.95. How were Ono Pharmaceutical's earnings last quarter? Ono Pharmaceutical Co. (OTCMKTS:OPHLF) released its quarterly earnings data on Monday, February, 2nd. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.11. The business earned $892.70 million during the quarter, compared to analysts' expectations of $727.58 million. Ono Pharmaceutical had a trailing twelve-month return on equity of 9.77% and a net margin of 15.02%. How do I buy shares of Ono Pharmaceutical? Shares of OPHLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings2/02/2026Today10/04/2026Next Earnings (Estimated)10/29/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:OPHLF CIK940821 Webwww.ono.co.jp Phone(166) 263-5670Fax816-6263-2950Employees4,206Year Founded1717Profitability EPS (Trailing Twelve Months)$1.05 Trailing P/E Ratio14.24 Forward P/E Ratio14.95 P/E GrowthN/ANet Income$436.04 million Net Margins15.02% Pretax Margin17.96% Return on Equity9.77% Return on Assets7.63% Debt Debt-to-Equity Ratio0.08 Current Ratio3.28 Quick Ratio2.86 Sales & Book Value Annual Sales$3.43 billion Price / Sales2.05 Cash Flow$1.49 per share Price / Cash Flow10.04 Book Value$11.39 per share Price / Book1.31Miscellaneous Outstanding Shares469,908,000Free FloatN/AMarket Cap$7.03 billion OptionableNot Optionable Beta0.33 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:OPHLF) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...Paradigm Press | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | SponsoredHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ono Pharmaceutical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ono Pharmaceutical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
